8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), 19-22 July 2015, Vancouver, Canada
1 October 2015. Related: Conference reports.
IAS 8th Vancouver 2015
The PrEP experience: IAS 2015 and beyond
1 October 2015. Related: Conference reports, HIV prevention and transmission.
News and notes on HIV cure research from IAS 2015
1 October 2015. Related: Conference reports, Cure-related research.
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), 19 – 22 July 2015, Vancouver, Canada
1 August 2015. Related: Conference reports.
Tribute to Bob Munk: long-time HIV positive US treatment activist and educator
1 August 2015. Related: In memory, Conference reports.
Four reasons IAS 2015 will be a milestone HIV conference: a personal view
1 August 2015. Related: Conference reports, Antiretrovirals, Treatment strategies, HIV prevention and transmission.
Starting HIV treatment at high CD4 counts protects against both AIDS and non-AIDS events: overall and in subgroup analyses of START study
1 August 2015. Related: Conference reports, Antiretrovirals, Treatment strategies.
The option for same day antiretroviral therapy on diagnosis: the future model for HIV care
1 August 2015. Related: Conference reports, Treatment strategies, Treatment access, Treatment advocacy, Other news.
Pipeline ARVs at IAS 2015: doravirine, BMS-955176 and BMS-663068
1 August 2015. Related: Conference reports, Antiretrovirals.
New directions in the 2015 WHO ART guidelines
1 August 2015. Related: Conference reports, Treatment access, Guidelines.
Rapid implementation of the 2013 WHO ART guidelines
1 August 2015. Related: Conference reports, Antiretrovirals, Guidelines.
Large variation across countries in meeting UNAIDS 90-90-90 targets
1 August 2015. Related: Conference reports, Treatment access.
Low dose boosted atazanavir is non-inferior to standard dose in Thai treatment optimisation study: LASA
1 August 2015. Related: Conference reports, Treatment strategies.
HPTN 052: no HIV transmissions on effective ART but only limited data on viral failure and drug resistance
1 August 2015. Related: Conference reports, Treatment strategies, HIV prevention and transmission.
Dispersible tablet formulation of dolutegravir is bioequivalent to the granule formulation
1 August 2015. Related: Conference reports, Paediatric care.
New case of remission in a perinatally infected teenager
1 August 2015. Related: Conference reports, Cure-related research.
IAS 2015: accessing webcasts and abstracts online
1 August 2015. Related: Conference reports.